@prefix bqmodel: <http://biomodels.net/model-qualifiers/> .
@prefix dc: <http://purl.org/dc/elements/1.1/> .
@prefix prism: <http://prismstandard.org/namespaces/basic/2.0/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

<http://omex-library.org/BIOMD0000000552.omex> bqmodel:isDescribedBy <local:00001>,
        <local:00002> ;
    prism:keyword "Biomodels" ;
    dc:description """<body xmlns="http://www.w3.org/1999/xhtml">
  <div class="dc:title">Ehrenstein2000 - Positive-Feedback model for
the loss of acetylcholine in Alzheimer&apos;s disease</div>
  <div class="dc:description">Curated model derived from
<h1 style="font-family: helvetica, &apos;trebuchet MS&apos;, arial, sans-serif;">
BIOMD0000000553</h1></div>
  <div class="dc:bibliographicCitation">
    <p>This model is described in the article:</p>
    <div class="bibo:title">
      <a href="http://identifiers.org/pubmed/10863547" title="Access to this publication">A positive-feedback model
    for the loss of acetylcholine in Alzheimer&apos;s disease.</a>
    </div>
    <div class="bibo:authorList">Ehrenstein G, Galdzicki Z, Lange
  GD.</div>
    <div class="bibo:Journal">Ann. N. Y. Acad. Sci. 2000; 899:
  283-291</div>
    <p>Abstract:</p>
    <div class="bibo:abstract">
      <p>We describe a two-component positive-feedback system that
    could account for the large reduction of acetylcholine that is
    characteristic of patients with Alzheimer&apos;s disease (AD). One
    component is beta-amyloid-induced apoptosis of cholinergic
    cells, leading to a decrease in acetylcholine. The other
    component is an increase in the concentration of beta-amyloid
    in response to a decrease in acetylcholine. We describe each
    mechanism with a differential equation, and then solve the two
    equations numerically. The solution provides a description of
    the time course of the reduction of acetylcholine in AD
    patients that is consistent with epidemiological data. This
    model may also provide an explanation for the significant, but
    lesser, decrease of other neurotransmitters that is
    characteristic of AD.</p>
    </div>
  </div>
  <div class="dc:publisher">
    <p>This model is hosted on 
  <a href="http://www.ebi.ac.uk/biomodels/">BioModels Database</a>
  and identified by: 
  <a href="http://identifiers.org/biomodels.db/BIOMD0000000552">BIOMD0000000552</a>.</p>
    <p>To cite BioModels Database, please use: 
  <a href="http://identifiers.org/pubmed/20587024" title="Latest BioModels Database publication">BioModels Database:
  An enhanced, curated and annotated resource for published
  quantitative kinetic models</a>.</p>
  </div>
  <div class="dc:license">
    <p>To the extent possible under law, all copyright and related or
  neighbouring rights to this encoded model have been dedicated to
  the public domain worldwide. Please refer to 
  <a href="http://creativecommons.org/publicdomain/zero/1.0/" title="Access to: CC0 1.0 Universal (CC0 1.0), Public Domain Dedication">CC0
  Public Domain Dedication</a> for more information.</p>
  </div>
</body>""" ;
    dc:title "A positive-feedback model for the loss of acetylcholine in Alzheimer's disease" .

<local:00001> rdfs:label "G. Ehrenstein, Z. Galdzicki & G.D. Lange. The choline-leakage hypothesis for the loss of acetylcholine in Alzheimer's disease. Biophysical Journal 73, 3 (1997)." ;
    dc:identifier <http://identifiers.org/doi/10.1016/S0006-3495(97)78160-8> .

<local:00002> rdfs:label "GERALD EHRENSTEIN, ZYGMUNT GALDZICKI & G. DAVID LANGE. A positive-feedback model for the loss of acetylcholine in Alzheimer's disease. Annals of the New York Academy of Sciences 899 (2000)." ;
    dc:identifier <http://identifiers.org/doi/10.1111/j.1749-6632.2000.tb06194.x> .

